|
MechanismHIV envelope protein gp120 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with South Asia Healthcare & Research Pvt Ltd.
0 Patents (Medical) associated with South Asia Healthcare & Research Pvt Ltd.
100 Deals associated with South Asia Healthcare & Research Pvt Ltd.
100 Translational Medicine associated with South Asia Healthcare & Research Pvt Ltd.